role for mrd assessment in al amyloidosis?
Published 4 years ago • 41 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
2:13
advances & unanswered questions about the role of mrd in al amyloidosis
-
2:04
novel techniques being used for mrd assessment in aml & the importance of considering oligoclonality
-
1:51
the role of mass spectrometry in response assessment in patients with al amyloidosis
-
3:21
insights into the management of systemic al amyloidosis
-
1:18
overview of the updated nccn clinical practice guidelines for systemic al amyloidosis
-
1:57
mrd negativity and response in al amyloidosis
-
5:14
current status & updates in the management of al amyloidosis
-
0:48
asciminib for the treatment of cml
-
1:16
considering enrolment in clinical trials for patients with amyloidosis
-
3:27
the role of mrd in aml regulatory decision making
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
1:11
current approaches for managing r/r al amyloidosis
-
4:05
al amyloidosis special session highlights: therapeutic advances and ongoing trials in the field
-
0:53
an overview of the different modalities used to assess mrd in aml
-
4:22
the role of mrd in aml
-
1:26
the current role of mrd in aml and challenges with implementing this in clinical practice
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
0:52
tocilizumab for aa amyloidosis
-
3:01
novel promising agents and clinical trials in amyloidosis